Correlation between ApoA1 gene polymorphism and efficacy of Qishen Yiqi dripping pill

ZHAO Guang-rong,ZHANG Heng-ming,XIAO Min

2008-01-01

Abstract:[Objective] To explore the relationship between single nucleotide polymorphism(SNP) of apolipoprotein A1(ApoA1) gene and efficacy of Qishen Yiqi(QSYQ) dripping pills on qi deficiency and blood stasis type of coronary heart disease.[Methods] Forty-two patients received QSYQ dripping pills for one month.The syndromes were scored,and blood samples were taken before and after treatment.The contents of blood fat,blood sugar and apoA and apoB were detected and the DNA was extracted from the leukocyte of the blood samples,and then the first extron of ApoA1 gene was amplified by polymerase chain reaction.The polymorphic site was detected by sequencing.[Results] Four significant mutant sites were found in ApoA1 gene.Between mutant groups and normal groups,the subtract values of deficiency of vital energy,lassitude,spontaneous perspiration,chest pain,suffocative sensation in the chest,palpitation,dark purple face and total syndrome score weren't significantly different(P>0.05).The subtract values of blood glucose,triglyceride,and apolipoproteins weren't also significantly different(P>0.05).[Conclusions] Four SNP sites in ApoA1 cann't affect the efficacy of QSYQ dripping pills on qi deficiency and blood stasis type of coronary heart disease.